Your browser doesn't support javascript.
loading
Multilayered Immunity by Tissue-Resident Lymphocytes in Cancer.
Li, Ming O; Zhang, Jing; Xu, Zijian; Zhang, Xian; Li, Peng; Cornish, Andrew E.
Afiliação
  • Li MO; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; email: lim@mskcc.org.
  • Zhang J; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Xu Z; Immunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School of Biomedical Sciences, Cornell University, New York, NY, USA.
  • Zhang X; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; email: lim@mskcc.org.
  • Li P; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; email: lim@mskcc.org.
  • Cornish AE; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; email: lim@mskcc.org.
Annu Rev Immunol ; 42(1): 647-677, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38424658
ABSTRACT
Lymphocytes spanning the entire innate-adaptive spectrum can stably reside in tissues and constitute an integral component of the local defense network against immunological challenges. In tight interactions with the epithelium and endothelium, tissue-resident lymphocytes sense antigens and alarmins elicited by infectious microbes and abiotic stresses at barrier sites and mount effector responses to restore tissue homeostasis. Of note, such a host cell-directed immune defense system has been recently demonstrated to surveil epithelial cell transformation and carcinoma development, as well as cancer cell metastasis at selected distant organs, and thus represents a primordial cancer immune defense module. Here we review how distinct lineages of tissue-resident innate lymphoid cells, innate-like T cells, and adaptive T cells participate in a form of multilayered cancer immunity in murine models and patients, and how their convergent effector programs may be targeted through both shared and private regulatory pathways for cancer immunotherapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Inata / Neoplasias Limite: Animals / Humans Idioma: En Revista: Annu Rev Immunol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Inata / Neoplasias Limite: Animals / Humans Idioma: En Revista: Annu Rev Immunol Ano de publicação: 2024 Tipo de documento: Article